| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 244.86▲ | 244.78▲ | 244.53▲ | 245.29▼ | 246.51▼ |
| MA10 | 244.66▲ | 244.33▲ | 244.13▲ | 246.44▼ | 257.68▼ |
| MA20 | 244.26▲ | 244.45▲ | 244.47▲ | 248.54▼ | 261.91▼ |
| MA50 | 244.39▲ | 245.09▲ | 246.51▼ | 260.80▼ | 244.47▲ |
| MA100 | 244.96▲ | 246.77▼ | 246.95▼ | 261.55▼ | 231.59▲ |
| MA200 | 246.77▼ | 247.35▼ | 255.10▼ | 249.66▼ | 219.63▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.083▲ | 0.207▲ | 0.224▲ | 0.325▲ | -4.033▼ |
| RSI | 55.808▲ | 52.713▲ | 49.648▼ | 35.536▼ | 44.878▼ |
| STOCH | 74.215 | 69.918 | 45.796 | 43.086 | 13.553▼ |
| WILL %R | -19.431▲ | -16.735▲ | -63.005 | -60.607 | -89.728▼ |
| CCI | 51.705 | 56.852 | 17.452 | -98.291 | -108.497▼ |
|
Monday, September 28, 2026 01:00 AM
Achieved 40.3% ORR with evorpacept plus trastuzumab, ramucirumab and paclitaxel versus 26.6% for control, with response rates increasing to 63.6% ...
|
|
Sunday, September 20, 2026 03:00 PM
ALX Oncology Holdings Inc. is a clinical-stage biotechnology company advancing a pipeline of therapies designed to treat cancer and extend patients’ lives. The Company's le ...
|
|
Monday, September 14, 2026 11:15 PM
On August 3, Alexander's Inc. (NYSE:ALX) reported second-quarter net income of $155.4 million, more than 25 times what it earned in the same quarter of 2025. That kind of jump looks like a breakout ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/10/26 | 244.22 | 245.67 | 242.955 | 245.23 | 34,466 |
| 02/10/26 | 244.14 | 246.83 | 242.215 | 243.86 | 30,552 |
| 01/10/26 | 245.19 | 245.31 | 240.17 | 243.83 | 24,199 |
| 30/09/26 | 245.19 | 247.40 | 244.77 | 246.50 | 31,505 |
| 29/09/26 | 249.76 | 253.015 | 247.02 | 247.02 | 36,363 |
| 28/09/26 | 247.65 | 250.92 | 247.65 | 249.08 | 27,943 |
| 25/09/26 | 244.87 | 249.43 | 243.2725 | 247.12 | 58,484 |
| 24/09/26 | 249.08 | 250.28 | 244.51 | 245.46 | 41,871 |
| 23/09/26 | 248.84 | 248.84 | 245.45 | 247.87 | 30,735 |
| 22/09/26 | 245.36 | 250.00 | 245.36 | 248.40 | 40,334 |
|
|
||||
|
|
||||
|
|